IDT approved to manufacture mRNA vaccines

Melbourne drug development and manufacturing company IDT Australia has received extensions to its manufacturing licence from the Therapeutic Goods Administration effectively completing its program to bring the company’s sterile manufacturing facility into a state of readiness to manufacture Covid-19 mRNA technology vaccines. The new approvals allow the company to manufacture sterile injection and sterile solution…